FMF StripAssay®
Familial Mediterranean Fever Mutation Detection
The FMF StripAssay® detects mutations associated with Familial Mediterranean Fever (FMF), the most common inherited inflammatory disorder, characterized by recurrent bouts of fever and painful inflammation. Early genetic identification supports prophylactic treatment to prevent severe amyloidosis complications.
Key Features
FMF Genetic Screening
Detects mutations associated with Familial Mediterranean Fever, the most common inherited inflammatory disorder.
Amyloidosis Prevention
Early genetic identification supports prophylactic colchicine treatment to prevent severe amyloidosis and kidney failure.
Symptom Differentiation
Distinguishes FMF from other inflammatory conditions presenting with recurrent fever, abdominal pain, and joint inflammation.
PCR & Reverse Hybridization
Based on reverse hybridization of biotinylated PCR products for reliable FMF mutation detection.
For Research Use Only (RUO)
FMF StripAssay® is intended for research use only in the United States and is not FDA-cleared for diagnostic use.